⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PBM News
Psyence Biomedical Ltd. Common Shares
Pacific Bay Expands Haskins-Reed Critical Minerals Project Near Cassiar, BC Via Option Deal with Eagle Plains Resources Ready to Announce with Confidence?
newsfilecorp.com
PBM
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
globenewswire.com
PBM
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
globenewswire.com
PBM
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
globenewswire.com
PBM
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
globenewswire.com
PBM
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
globenewswire.com
PBM
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
globenewswire.com
PBM
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
globenewswire.com
PBM
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders
globenewswire.com
PBM
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway
globenewswire.com
PBM